{"id":"https://openalex.org/W1995232262","doi":"https://doi.org/10.1111/j.1463-1326.2011.01411.x","title":"A randomized\u2010controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose\u2013lipid control in type 2 diabetes","display_name":"A randomized\u2010controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose\u2013lipid control in type 2 diabetes","publication_year":2011,"publication_date":"2011-04-14","ids":{"openalex":"https://openalex.org/W1995232262","doi":"https://doi.org/10.1111/j.1463-1326.2011.01411.x","mag":"1995232262","pmid":"https://pubmed.ncbi.nlm.nih.gov/21492364"},"language":"en","primary_location":{"id":"doi:10.1111/j.1463-1326.2011.01411.x","doi":"https://doi.org/10.1111/j.1463-1326.2011.01411.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2011.01411.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074058456","display_name":"Alice P.S. Kong","orcid":"https://orcid.org/0000-0001-8927-6764","observed_orcids":["https://orcid.org/0000-0001-8927-6764"]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]},{"id":"https://openalex.org/I4210114914","display_name":"Prince of Wales Hospital","ror":"https://ror.org/02827ca86","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I1294586568","https://openalex.org/I4210114914"]}],"countries":["CN","HK"],"is_corresponding":false,"raw_author_name":"A. P. S. Kong","raw_affiliation_strings":["Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China","Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China","These authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China","institution_ids":["https://openalex.org/I177725633","https://openalex.org/I4210114914"]},{"raw_affiliation_string":"Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China","institution_ids":["https://openalex.org/I177725633","https://openalex.org/I4210114914"]},{"raw_affiliation_string":"These authors contributed equally to this work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101570878","display_name":"Akira Yamasaki","orcid":"https://orcid.org/0000-0001-5175-2729","observed_orcids":["https://orcid.org/0000-0001-5175-2729"]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"A. Yamasaki","raw_affiliation_strings":["Daiichi Sankyo Co., Ltd, Hiromachi, Shinagawa-ku, Tokyo, Japan","These authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Daiichi Sankyo Co., Ltd, Hiromachi, Shinagawa-ku, Tokyo, Japan","institution_ids":["https://openalex.org/I4210104626"]},{"raw_affiliation_string":"These authors contributed equally to this work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085222165","display_name":"Risa Ozaki","orcid":"https://orcid.org/0000-0002-2564-0560","observed_orcids":["https://orcid.org/0000-0002-2564-0560"]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]},{"id":"https://openalex.org/I4210114914","display_name":"Prince of Wales Hospital","ror":"https://ror.org/02827ca86","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I1294586568","https://openalex.org/I4210114914"]}],"countries":["CN","HK"],"is_corresponding":false,"raw_author_name":"R. Ozaki","raw_affiliation_strings":["Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China","institution_ids":["https://openalex.org/I177725633","https://openalex.org/I4210114914"]}]},{"author_position":"middle","author":{"id":null,"display_name":"H. Saito","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"H. Saito","raw_affiliation_strings":["Daiichi Sankyo Co., Ltd, Hiromachi, Shinagawa-ku, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Daiichi Sankyo Co., Ltd, Hiromachi, Shinagawa-ku, Tokyo, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":null,"display_name":"T. Asami","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T. Asami","raw_affiliation_strings":["Daiichi Sankyo Co., Ltd, Hiromachi, Shinagawa-ku, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Daiichi Sankyo Co., Ltd, Hiromachi, Shinagawa-ku, Tokyo, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Ohwada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"S. Ohwada","raw_affiliation_strings":["Daiichi Sankyo Co., Ltd, Hiromachi, Shinagawa-ku, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Daiichi Sankyo Co., Ltd, Hiromachi, Shinagawa-ku, Tokyo, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114444434","display_name":"Gary T C Ko","orcid":"https://orcid.org/0000-0001-9764-9321","observed_orcids":["https://orcid.org/0000-0001-9764-9321"]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]},{"id":"https://openalex.org/I2802582348","display_name":"Alice Ho Miu Ling Nethersole Hospital","ror":"https://ror.org/01g171x08","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I1294586568","https://openalex.org/I2802582348"]},{"id":"https://openalex.org/I4210114914","display_name":"Prince of Wales Hospital","ror":"https://ror.org/02827ca86","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I1294586568","https://openalex.org/I4210114914"]}],"countries":["CN","HK"],"is_corresponding":false,"raw_author_name":"G. T. C. Ko","raw_affiliation_strings":["Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China","Department of Medicine, Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong, China","Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China","institution_ids":["https://openalex.org/I177725633","https://openalex.org/I4210114914"]},{"raw_affiliation_string":"Department of Medicine, Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong, China","institution_ids":["https://openalex.org/I2802582348"]},{"raw_affiliation_string":"Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China","institution_ids":["https://openalex.org/I177725633","https://openalex.org/I4210114914"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041610413","display_name":"Carlos King Ho Wong","orcid":"https://orcid.org/0000-0002-6895-6071","observed_orcids":["https://orcid.org/0000-0002-6895-6071"]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]},{"id":"https://openalex.org/I4210114914","display_name":"Prince of Wales Hospital","ror":"https://ror.org/02827ca86","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I1294586568","https://openalex.org/I4210114914"]}],"countries":["CN","HK"],"is_corresponding":false,"raw_author_name":"C. K. Wong","raw_affiliation_strings":["Department of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China","institution_ids":["https://openalex.org/I177725633","https://openalex.org/I4210114914"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103419604","display_name":"G. T. C. Leung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]},{"id":"https://openalex.org/I4210114914","display_name":"Prince of Wales Hospital","ror":"https://ror.org/02827ca86","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I1294586568","https://openalex.org/I4210114914"]}],"countries":["CN","HK"],"is_corresponding":false,"raw_author_name":"G. T. C. Leung","raw_affiliation_strings":["Qualigenics Diabetes Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Qualigenics Diabetes Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China","institution_ids":["https://openalex.org/I177725633","https://openalex.org/I4210114914"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056765561","display_name":"K. F. Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799752757","display_name":"Kwong Wah Hospital","ror":"https://ror.org/03s9jrm13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I1294586568","https://openalex.org/I2799752757"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"K. F. Lee","raw_affiliation_strings":["Department of Medicine, Kwong Wah Hospital, Kowloon, Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Kwong Wah Hospital, Kowloon, Hong Kong, China","institution_ids":["https://openalex.org/I2799752757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056388514","display_name":"Chi-Kin Yeung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801921532","display_name":"Pamela Youde Nethersole Eastern Hospital","ror":"https://ror.org/009s7a550","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I1294586568","https://openalex.org/I2801921532"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"C. Y. Yeung","raw_affiliation_strings":["Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong, China","institution_ids":["https://openalex.org/I2801921532"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091832416","display_name":"Juliana C.N. Chan","orcid":"https://orcid.org/0000-0003-1325-1194","observed_orcids":["https://orcid.org/0000-0003-1325-1194"]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]},{"id":"https://openalex.org/I4210114914","display_name":"Prince of Wales Hospital","ror":"https://ror.org/02827ca86","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I1294586568","https://openalex.org/I4210114914"]}],"countries":["CN","HK"],"is_corresponding":false,"raw_author_name":"J. C. N. Chan","raw_affiliation_strings":["Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China","Hong Kong Institute of Diabetes and Obesity, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China","Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China","institution_ids":["https://openalex.org/I177725633","https://openalex.org/I4210114914"]},{"raw_affiliation_string":"Hong Kong Institute of Diabetes and Obesity, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China","institution_ids":["https://openalex.org/I177725633","https://openalex.org/I4210114914"]},{"raw_affiliation_string":"Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China","institution_ids":["https://openalex.org/I177725633","https://openalex.org/I4210114914"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5101570878"],"corresponding_institution_ids":["https://openalex.org/I4210104626"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":1.0477,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.77933201,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"13","issue":"9","first_page":"806","last_page":"813"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.02449999935925007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ppargamma-agonists","display_name":"PPAR\u03b3 agonists","score":0.8339999914169312},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9869999885559082},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9850000143051147},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9350000023841858},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8569999933242798},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9850000143051147},{"id":"https://openalex.org/keywords/lipid-management","display_name":"lipid control","score":0.7990000247955322},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.7689999938011169},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.9779999852180481},{"id":"https://openalex.org/keywords/chinese-patients","display_name":"Chinese patients","score":0.6650000214576721},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.7620000243186951},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.6290000081062317},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.8489999771118164},{"id":"https://openalex.org/keywords/antidiabetic-efficacy","display_name":"antidiabetic efficacy","score":0.39899998903274536}],"concepts":[{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.9127193689346313},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8346434235572815},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7632650136947632},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7179573774337769},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5946627259254456},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5668450593948364},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.5332716703414917},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5095165371894836},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4863319993019104},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.473202645778656},{"id":"https://openalex.org/C2776923340","wikidata":"https://www.wikidata.org/wiki/Q1393556","display_name":"Thiazolidinedione","level":4,"score":0.4710913598537445},{"id":"https://openalex.org/C2778270857","wikidata":"https://www.wikidata.org/wiki/Q2723972","display_name":"Lipid profile","level":3,"score":0.4582492709159851},{"id":"https://openalex.org/C202061045","wikidata":"https://www.wikidata.org/wiki/Q7200267","display_name":"Placebo-controlled study","level":5,"score":0.4413226246833801},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.42085713148117065},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4181944727897644},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.36148470640182495},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.2690524458885193},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.18223172426223755},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.05327802896499634},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044466","descriptor_name":"Asian People","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047495","descriptor_name":"PPAR gamma","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D050356","descriptor_name":"Lipid Metabolism","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1463-1326.2011.01411.x","doi":"https://doi.org/10.1111/j.1463-1326.2011.01411.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2011.01411.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:21492364","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21492364","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1980115178","https://openalex.org/W1998227193","https://openalex.org/W2004214012","https://openalex.org/W2037096787","https://openalex.org/W2056526409","https://openalex.org/W2056724510","https://openalex.org/W2081276121","https://openalex.org/W2109928490","https://openalex.org/W2126950530","https://openalex.org/W2127125241","https://openalex.org/W2131490500","https://openalex.org/W2140161503","https://openalex.org/W2159969745","https://openalex.org/W2160234571","https://openalex.org/W2171646682","https://openalex.org/W2910617129"],"related_works":["https://openalex.org/W2012211007","https://openalex.org/W2150159281","https://openalex.org/W2183844286","https://openalex.org/W2124269792","https://openalex.org/W2049240819","https://openalex.org/W2374808498","https://openalex.org/W4386239327","https://openalex.org/W2037447341","https://openalex.org/W2079614274","https://openalex.org/W2356306841"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"examine":[2],"the":[3,97,130,147,155,165,170,176,182,189,219,256,264],"efficacy,":[4],"safety":[5],"and":[6,14,20,26,54,76,88,173,186,212,222,259,273],"tolerability":[7],"of":[8,59,96,110,126],"rivoglitazone,":[9],"a":[10,41,50,119],"novel":[11],"thiazolidinedione":[12],"(TZD),":[13],"explore":[15],"its":[16],"effects":[17],"on":[18],"glucose":[19,79],"lipid":[21],"control":[22,69,279],"compared":[23,227,250],"to":[24,74,81,128,140,193,228,232,251,287],"placebo":[25,156,190,229,265],"pioglitazone":[27,105,184,257],"in":[28,136,146,160,164,169,175,181,188,198,208,214,218,242,246,255,263,280],"Chinese":[29,61,281],"type":[30,62,282],"2":[31,63,283],"diabetic":[32,64,284],"patients":[33,65,91,244,253,285],"who":[34],"are":[35],"treatment":[36,99,201],"na\u00cfve":[37],"or":[38,114],"treated":[39],"with":[40,66,154],"single":[42],"oral":[43],"blood":[44],"glucose-lowering":[45],"drug.":[46],"METHODS:":[47],"This":[48],"was":[49,240],"double-blind,":[51],"randomized,":[52],"placebo-":[53],"active-controlled":[55],"study.":[56],"A":[57],"total":[58],"287":[60],"suboptimal":[67],"glycaemic":[68,278],"(defined":[70],"as":[71,134],"HbA1c":[72,137,161],"\u22656.5":[73],"<10%":[75],"fasting":[77],"plasma":[78],"\u22657":[80],"\u226415":[82],"mmol/l)":[83],"were":[84,92,162,196,216],"enrolled.":[85],"One":[86],"hundred":[87],"seventy-four":[89],"eligible":[90],"randomized":[93],"into":[94],"one":[95,260],"five":[98],"arms":[100],"for":[101],"12":[102,234],"weeks:":[103],"placebo,":[104,194],"30":[106],"mg":[107,116,224],"daily,":[108],"rivoglitazone":[109,148,178,220,248],"dose":[111,152],"0.5,":[112],"1.0":[113],"1.5":[115,223],"daily.":[117],"In":[118],"full":[120],"set":[121],"analysis,":[122],"we":[123],"used":[124],"analysis":[125],"covariance":[127],"compare":[129],"primary":[131],"endpoint":[132],"defined":[133],"change":[135],"from":[138,230],"baseline":[139,231],"week":[141,233],"12/last":[142],"observation":[143],"carried":[144],"forward":[145],"group":[149,172,185,258],"at":[150],"each":[151],"level":[153],"group.":[157,191,266],"RESULTS:":[158],"Changes":[159],"-0.11%":[163],"0.5-mg":[166],"group;":[167,179],"-0.22%":[168],"1-mg":[171],"-0.17%":[174],"1.5-mg":[177],"-0.06%":[180],"30-mg":[183],"0.61%":[187],"Compared":[192],"changes":[195],"significant":[197],"all":[199,247],"active":[200],"groups":[202,249],"(all":[203],"p":[204],"<":[205,236],"0.05).":[206,237],"Increase":[207],"high-density":[209],"lipoprotein":[210],"cholesterol":[211],"decrease":[213],"triglyceride":[215],"observed":[217],"1":[221],"groups,":[225],"respectively,":[226],"(p":[235],"Drug-related":[238],"oedema":[239],"reported":[241],"eight":[243],"(7.7%)":[245],"six":[252],"(16.2%)":[254],"patient":[261],"(3.0%)":[262],"CONCLUSIONS:":[267],"Rivoglitazone":[268],"is":[269],"an":[270],"efficacious,":[271],"safe":[272],"well-tolerated":[274],"TZD":[275],"which":[276],"improved":[277],"up":[286],"3":[288],"months.":[289]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}